bioRxivBioinformaticsPreprint
Functional biological paths altered in Alzheimer's disease: from genes to bile acids
Priyanka GorijalaiD, Kwangsik T. NhoiD, Shannon L. RisacheriD, Rima F Kaddurah-DaoukiD, Andrew J. SaykiniD, Jingwen YaniD
Abstract
Large-scale genome wide association studies (GWASs) have been performed in search for risk genes for Alzheimers disease (AD). Despite the significant progress, replicability of genetic findings and their translation into targetable mechanisms related to the disease pathogenesis remains a challenge. Given that bile acids have been suggested in recent metabolic studies as potential age-related metabolic factors associated with AD, we integrated genomic and metabolomic data together with heterogeneous biological networks and investigated the potential cascade of effect of genetic variations to proteins, bile acids and ultimately AD brain phenotypes. Particularly, we leveraged functional protein interaction networks and metabolic networks and focused on the genes directly interacting with AD-altered bile acids and their functional regulators. We examined the association of all the SNPs located in those candidate genes with AD brain imaging phenotypes, and identified multiple AD risk SNPs whose downstream genes and bile acids were also found to be altered in AD. These AD related markers span from genetics to metabolomics, forming functional biological paths connecting across multiple-omics layers, and give valuable insights into the underlying mechanism of AD.
- organism: human
- assay: GWAS summary statistics
- assay: metabolomics
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer’s risk factors among 1,111 cohort participants
Burcu F. Darst, Qiongshi Lu, … Corinne D. Engelman·Genetic EpidemiologyPeer-reviewed·May 18, 2019
- Identifying differences in bile acid pathways for cholesterol clearance in Alzheimer’s disease using metabolic networks of human brain regions
Priyanka Baloni, Cory C. Funk, … Nathan D. Price·bioRxiv·Oct 1, 2019
- Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's Disease related proteins
Stephanie R. Oatman, Joseph S. Reddy, … Nilüfer Ertekin‐Taner·Molecular NeurodegenerationPeer-reviewed·Jan 6, 2023
- Genome-Wide Association Study of Brain Connectivity Changes for Alzheimer's Disease
Samar S. M. Elsheikh, Emile Rugamika Chimusa, … Alessandro Crimi·Scientific ReportsPeer-reviewed·Jan 29, 2020
- Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brains
Brenna C. Novotny, María Victoria Fernández, … Oscar Harari·medRxiv·Nov 4, 2021
- Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap with metabolic markers
Sara Elizabeth Stinson, Alexey A. Shadrin, … Ole A. Andreassen·medRxiv·Jul 31, 2025